Skip to content

A Clinico-Comparative trial to study the effects of Bhallatakadi Churna and Hingwadi Churna in the Management of Amavata.

A Clinico-Comparative Study of Bhallatakadi Churna and Hingwadi Churna in the Management of Amavata.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026129
Enrollment
15
Registered
2020-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

Intervention1: Hingwadi churna: Randomly patients will be selected for group-B medicine which is Hingwadi Churna is given to them in 9 gm divided in to three doses/day(3gm x TDS) before meal with ushn

Sponsors

Government Akhandanand Ayurved Mahavidhyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs & symptoms of Amavata mentioned in Classical texts will be selected. ����मर�द�Sर��िस�त�ष�णा �लस�य� ��रव� ��वर: | �पा�: श�नता��ानामामवातस�य ल��षणम� || [मा.नि] � According to American College of Rheumatology 2010, 1. Present with typically RA pain and stiffness in multiple joints 2.Morning stiffness lasting more than one hour 3. Boggy swelling due to synovitis 4. Present with more indolent arthralgia before onset of clinically apparent joint swelling and low grade fever. Age : Patients will be selected between 18 to 60 years of age.

Exclusion criteria

Exclusion criteria: 1.The patients suffering from systemic disorders like Cardiac disease, Cancer, Tuberculosis, and other debilitating diseases which may lead to fatal condition for the Patient at any time. 2. Patients below 18 year and above 60 year will be excluded. 3.Patients of chronic condition (more than 3 years will be excluded.) 4.Patients having uncontrolled DM, Hypertention etc. will be excluded. 5.Patient suffering with Asadhya Lakshana as â??Sarva Dehchara Shothaâ?? and other such Lakshana mentioned in Ayurvedic classics. 6.Patients diagnosed with Ayurveda diagnosis like Sandhivata, Sarvanga Vata etc. will be excluded.

Design outcomes

Primary

MeasureTime frame
Results will be assessed on the basis of relief in signs and symptoms of Amavata by specific scoring pattern.Timepoint: 6 Weeks.

Secondary

MeasureTime frame
By comparing the effects of both the drugs on ESR and RA TITER before and after treatment.Timepoint: 6 Weeks.

Countries

India

Contacts

Public ContactDrMNShaikh

Government Akhandanand Ayurved college

Shaikhmustak542@gmail.com9824440708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026